A detailed history of Capital Advisory Group Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Advisory Group Advisory Services, LLC holds 7,901 shares of ABBV stock, worth $1.39 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
7,901
Previous 7,787 1.46%
Holding current value
$1.39 Million
Previous $1.34 Million 16.85%
% of portfolio
0.62%
Previous 0.57%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $18,677 - $22,723
114 Added 1.46%
7,901 $1.56 Million
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $67,798 - $79,172
438 Added 5.96%
7,787 $1.34 Million
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $6,552 - $7,466
41 Added 0.56%
7,349 $1.34 Million
Q4 2023

Jan 09, 2024

SELL
$137.6 - $154.97 $12,934 - $14,567
-94 Reduced 1.27%
7,308 $1.13 Million
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $988,833 - $1.14 Million
7,402 New
7,402 $1.1 Million
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $17,353 - $19,984
120 Added 1.56%
7,823 $1.25 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $22,406 - $26,870
-162 Reduced 2.06%
7,703 $1.25 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $5,636 - $6,465
-42 Reduced 0.53%
7,865 $1.06 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $6,192 - $7,873
-45 Reduced 0.57%
7,907 $1.2 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $32,995 - $40,937
250 Added 3.25%
7,952 $1.29 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $21,915 - $27,729
-204 Reduced 2.58%
7,702 $1.04 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $69,479 - $78,869
653 Added 9.0%
7,906 $853,000
Q2 2021

Nov 12, 2021

BUY
$105.21 - $117.21 $25,671 - $28,599
244 Added 3.48%
7,253 $817,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $17,391 - $19,145
170 Added 2.49%
7,009 $759,000
Q4 2020

Feb 18, 2021

BUY
$80.49 - $108.67 $178,607 - $241,138
2,219 Added 48.03%
6,839 $733,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $94,157 - $110,509
-1,096 Reduced 19.17%
4,620 $405,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $406,176 - $543,524
5,536 Added 3075.56%
5,716 $561,000
Q1 2020

May 18, 2020

BUY
$64.5 - $97.79 $11,610 - $17,602
180 New
180 $14,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $12,694 - $15,884
-176 Closed
0 $0
Q3 2019

May 28, 2020

SELL
$62.98 - $75.72 $19,649 - $23,624
-312 Reduced 63.93%
176 $14,000
Q2 2019

May 28, 2020

SELL
$65.7 - $83.98 $1,971 - $2,519
-30 Reduced 5.79%
488 $35,000
Q1 2019

May 28, 2020

SELL
$77.14 - $90.79 $715,319 - $841,895
-9,273 Reduced 94.71%
518 $42,000
Q4 2018

May 28, 2020

SELL
$77.85 - $96.01 $50,368 - $62,118
-647 Reduced 6.2%
9,791 $907,000
Q3 2018

May 28, 2020

SELL
$88.91 - $98.84 $3,734 - $4,151
-42 Reduced 0.4%
10,438 $987,000
Q2 2018

May 28, 2020

BUY
$89.78 - $106.23 $493,879 - $584,371
5,501 Added 110.48%
10,480 $975,000
Q1 2018

May 28, 2020

BUY
$92.01 - $123.21 $458,117 - $613,462
4,979 New
4,979 $470,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.